key: cord-0928997-cn1b1jvo
authors: Samara, Elpida; Ameerally, Phillip
title: Skin cancer surgery at the time of the covid-19 pandemic: a single center experience
date: 2021-04-19
journal: nan
DOI: 10.1016/j.adoms.2021.100083
sha: c486b76788247f81b41e3a9f8164c4f90cae1090
doc_id: 928997
cord_uid: cn1b1jvo

Elective operations were significantly reduced in order to eliminate, as much as possible, the risks of SARS -CoV-2 virus infection for both patients and medical personnel and to leave the clinical facilities and intensive care available for access to COVID patients. We looked at the total number of patients treated for skin cancer surgery at both hospitals from the 23rd of March 2020 till the 28th of May 2020, the demographic characteristics, the medical comorbidities, the pathologies operated on in day surgery regimens of care and the surgical outcomes. With regards to the site, more than one third of the patients were treated at a private hospital setting. Among the surgery complications identified there was one graft failure following excision of scalp lesion which histology confirmed regressed keratoacanthoma. Moreover, three infections associated with the lesions excised occurred and were treated with antibiotics. With regards to morbidity there was only one covid-19 infection among the patients that attended for skin cancer surgery and two deaths. The utilization of Covid-free locations, other than NHS hospitals, for elective surgery improved the efficiency of the service and together with the practical steps in theatre management and minimizing footfall, allowed the successful continuation of care during the pandemic.

The first confirmed case of SARS-CoV-2 Coronavirus disease in the UK was 24 on 29th January 2020 and it was the 23rd March that the UK-wide "stay at home" lockdown 25 healthcare systems who had to set up new intensive care units and separate clinical pathways 27 for infected patients 1 Anticipating complete redeployment of our staff and the inability to operate, we acted early 40 and prioritized urgent skin cancer cases as early diagnosis and treatment is important for 41 maximizing survival outcomes 6 . On the other hand, it is difficult to evaluate and prioritize 42 skin malignancies because skin cancer ranges from slowly progressing types that can be 43 monitored, to very aggressive forms that progress rapidly. A careful selection of patients who 44 needed treatment as soon as possible was conducted by the consultants Oral and Maxillofacial 45

Surgeons in our department. The risk of worsening of the disease within 30 days was the most 46 important factor for prioritization.

During the pandemic, we reorganization the OMFS department in order to minimise the risk 48 of COVID-19 infections among outpatients and staff . We were fortunate to be given theatre 49 space at the private sector and in main theatres at Northampton General Hospital. We 50 limiting the number of patients attending to only to the ones treated for skin cancer, asking the 52 patients to arrive at a designated time, alone, wearing appropriate Personal Protective 53 Equipment (PPE)typically a surgical face mask. Patients were also pre-warned about 54 COVID-19 symptoms beforehand and advised to cancel their appointment should they 55 develop any symptoms. We also asked the patients to self-isolate prior to attendance at the 56 hospital. We kept the minimum number of staff present at both sites in order to run the 57 service safely and efficiently. Finally, for the patients attending the NHS hospital we asked 58 them to use the entrance located at the rear of the hospital in order to avoid high footfall 59 within main corridors. Patients also had their temperatures checked prior to entering the 60 department. for an excision of a lesion in the scalp that histology confirmed Bowenoid actinic keratosis. 90

The patient was tested positive for covid-19 approximately 2 months after his attendance at 91 the department and he recovered fully. This is unlikely to be related to his hospital attendance. 92

With regards to deaths, there were two noted. One occurred in an 89 year old patient who 93 presented for excision of lesions on his temple and scalp. Both were histology confirmed 94 SCC. This patient was treated in a theatre environment at the private hospital as a day case 95 and discharged home following the procedure. He was previously diagnosed with clinically 96 prostate cancer and was currently on hormone therapy. The patient was admitted to the 97 hospital 6 days after the procedure and died the day after from aspiration pneumonia and 98 cardiac arrest. The second death was related to a 63 years old patient previously diagnosed 99 with advanced stage of lower rectal adenocarcinoma, advanced recurrent metastatic disease in the left lung, hilum and mediastinum that was treated for excision of an SCC at the scalp 101 region at the Maxillofacial outpatient department. A few days later the patient represented to 102 the department for revision of the local scalp defect due to dehiscence of the initial area of 103 surgery. Unfortunately, the patient died 1.5 months from the last visit to the department due to 104 to other members of staff as well as to the patients 7,8 . Only symptomatic healthcare staff were 133 offered testing during that time. Availability of screening tests for staff would be a desirable 134 adjunct to our current measures to reduce disease transmission. 135

The utilization of Covid-free locations, other than NHS hospitals, for elective surgery 136 improved the efficiency of the service and together with the practical steps in theatre 137 management and minimizing footfall, allowed the successful continuation of care during the 138 pandemic. As we expect COVID-19 will continue to affect life for the considerable future, we 139 hope that the results of this report can be used when considering oncological risk of delaying 140 surgery versus covid-19 transmission for patients that need treatment.

Skin cancer plastic surgery 154 during the COVID-19 pandemic

Reduction in skin cancer diagnoses in the UK during the 157

COVID-19 pandemic

Update on keratinocyte carcinomas

Clinical predictors of mortality due to COVID-162 19 based on an analysis of data of 150 patients from Wuhan, China

Plastic surgical management of 168 skin cancer patients during the COVID-19 pandemic

COVID-19: the case for health-care worker screening to prevent hospital 172 transmission

Communication: A safe skin cancer surgery set-up during 174 the COVID-19 crisis